questionsmedicales.fr
Procédures de chirurgie opératoire
Transplantation
Transplantation cellulaire
Transplantation cellulaire : Questions médicales fréquentes
Diagnostic
5
Transplantation cellulaire
Diagnostic médical
Compatibilité tissulaire
Transplantation cellulaire
Défaillance cellulaire
Symptômes
Évaluation de la santé
Transplantation cellulaire
Marqueurs biologiques
Transplantation cellulaire
Symptômes
5
Symptômes
Transplantation cellulaire
Rejet de greffe
Symptômes
Effets secondaires
Transplantation cellulaire
Types de cellules
Symptômes
Prévention
5
Prévention
Rejet de greffe
Mode de vie sain
Prévention
Traitements
5
Immunosuppresseurs
Transplantation cellulaire
Rejet de greffe
Traitements
Complications
Traitements
Types de cellules
Traitements
Suivi médical
Transplantation cellulaire
Complications
5
Complications
Transplantation cellulaire
Complications cardiovasculaires
Prévention
Signes d'alerte
Complications
Facteurs de risque
5
Facteurs de risque
Rejet de greffe
Mode de vie
Facteurs de risque
Médicaments
Facteurs de risque
Obésité
Facteurs de risque
Antécédents médicaux
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Transplantation cellulaire : Questions médicales les plus fréquentes",
"headline": "Transplantation cellulaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Transplantation cellulaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-01",
"dateModified": "2026-03-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Transplantation cellulaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Transplantation",
"url": "https://questionsmedicales.fr/mesh/D014180",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation",
"code": {
"@type": "MedicalCode",
"code": "D014180",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Transplantation d'ilots de Langerhans",
"alternateName": "Islets of Langerhans Transplantation",
"url": "https://questionsmedicales.fr/mesh/D016381",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation d'ilots de Langerhans",
"code": {
"@type": "MedicalCode",
"code": "D016381",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936.225.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Transplantation de cellules souches",
"alternateName": "Stem Cell Transplantation",
"url": "https://questionsmedicales.fr/mesh/D033581",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation de cellules souches",
"code": {
"@type": "MedicalCode",
"code": "D033581",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936.225.687"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Transplantation de cellules souches de sang du cordon",
"alternateName": "Cord Blood Stem Cell Transplantation",
"url": "https://questionsmedicales.fr/mesh/D036101",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation de cellules souches de sang du cordon",
"code": {
"@type": "MedicalCode",
"code": "D036101",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936.225.687.312"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Transplantation de cellules souches hématopoïétiques",
"alternateName": "Hematopoietic Stem Cell Transplantation",
"url": "https://questionsmedicales.fr/mesh/D018380",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation de cellules souches hématopoïétiques",
"code": {
"@type": "MedicalCode",
"code": "D018380",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936.225.687.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Transplantation de cellules souches de sang périphérique",
"alternateName": "Peripheral Blood Stem Cell Transplantation",
"url": "https://questionsmedicales.fr/mesh/D036102",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation de cellules souches de sang périphérique",
"code": {
"@type": "MedicalCode",
"code": "D036102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936.225.687.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Transplantation de cellules souches de sang périphérique",
"alternateName": "Peripheral Blood Stem Cell Transplantation",
"url": "https://questionsmedicales.fr/mesh/D036102",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation de cellules souches de sang périphérique",
"code": {
"@type": "MedicalCode",
"code": "D036102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936.225.687.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Transplantation de cellules souches mésenchymateuses",
"alternateName": "Mesenchymal Stem Cell Transplantation",
"url": "https://questionsmedicales.fr/mesh/D045164",
"about": {
"@type": "MedicalCondition",
"name": "Transplantation de cellules souches mésenchymateuses",
"code": {
"@type": "MedicalCode",
"code": "D045164",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.936.225.687.625"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Transplantation cellulaire",
"alternateName": "Cell Transplantation",
"code": {
"@type": "MedicalCode",
"code": "D017690",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Junichi Sugita",
"url": "https://questionsmedicales.fr/author/Junichi%20Sugita",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematology, Hokkaido University Hospital, Hokkaido, Japan."
}
},
{
"@type": "Person",
"name": "Takahiro Fukuda",
"url": "https://questionsmedicales.fr/author/Takahiro%20Fukuda",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Mohamad Mohty",
"url": "https://questionsmedicales.fr/author/Mohamad%20Mohty",
"affiliation": {
"@type": "Organization",
"name": "Hematology, Hôpital St. Antoine, Paris, France."
}
},
{
"@type": "Person",
"name": "Arnon Nagler",
"url": "https://questionsmedicales.fr/author/Arnon%20Nagler",
"affiliation": {
"@type": "Organization",
"name": "Chaim Sheba Medical Center, Tel-Hashomer, Israel."
}
},
{
"@type": "Person",
"name": "Irma Husain",
"url": "https://questionsmedicales.fr/author/Irma%20Husain",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Duke University, Durham, NC, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A Human Cerebral Organoid Model of Neural Cell Transplantation.",
"datePublished": "2023-07-21",
"url": "https://questionsmedicales.fr/article/37590518",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3791/64770"
}
},
{
"@type": "ScholarlyArticle",
"name": "Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review.",
"datePublished": "2023-09-15",
"url": "https://questionsmedicales.fr/article/37715361",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/ijd.16844"
}
},
{
"@type": "ScholarlyArticle",
"name": "An innovative cell-based transplantation therapy for an immature permanent tooth in an adult: a case report.",
"datePublished": "2024-06-01",
"url": "https://questionsmedicales.fr/article/38824565",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12903-024-04410-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37798633",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12916-023-03088-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early Clinical Outcomes of the First Commercialized Human Autologous Ex Vivo Cultivated Oral Mucosal Epithelial Cell Transplantation for Limbal Stem Cell Deficiency: Two Case Reports and Literature Review.",
"datePublished": "2023-05-18",
"url": "https://questionsmedicales.fr/article/37240280",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24108926"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Procédures de chirurgie opératoire",
"item": "https://questionsmedicales.fr/mesh/D013514"
},
{
"@type": "ListItem",
"position": 3,
"name": "Transplantation",
"item": "https://questionsmedicales.fr/mesh/D014180"
},
{
"@type": "ListItem",
"position": 4,
"name": "Transplantation cellulaire",
"item": "https://questionsmedicales.fr/mesh/D017690"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Transplantation cellulaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Transplantation cellulaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Transplantation cellulaire",
"description": "Comment diagnostiquer un besoin de transplantation cellulaire ?\nQuels tests sont utilisés pour évaluer la compatibilité ?\nQuels symptômes indiquent une défaillance cellulaire ?\nComment évaluer l'état de santé du receveur ?\nQuels marqueurs biologiques sont surveillés ?",
"url": "https://questionsmedicales.fr/mesh/D017690#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Transplantation cellulaire",
"description": "Quels symptômes peuvent survenir après une transplantation ?\nComment reconnaître un rejet de greffe ?\nQuels effets secondaires sont possibles ?\nLes symptômes varient-ils selon le type de cellules transplantées ?\nQuels signes d'infection doivent alerter ?",
"url": "https://questionsmedicales.fr/mesh/D017690#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Transplantation cellulaire",
"description": "Comment prévenir le rejet de greffe ?\nQuelles mesures d'hygiène sont recommandées ?\nComment éviter les infections post-transplantation ?\nQuels vaccins sont recommandés avant la transplantation ?\nComment maintenir un mode de vie sain après la transplantation ?",
"url": "https://questionsmedicales.fr/mesh/D017690#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Transplantation cellulaire",
"description": "Quels traitements sont administrés après une transplantation ?\nComment gérer le rejet de greffe ?\nQuelles sont les options de traitement en cas de complications ?\nLes traitements varient-ils selon le type de cellules ?\nQuel suivi est nécessaire après la transplantation ?",
"url": "https://questionsmedicales.fr/mesh/D017690#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Transplantation cellulaire",
"description": "Quelles sont les complications possibles après une transplantation ?\nComment gérer une infection post-transplantation ?\nQuels sont les risques de cancer après une transplantation ?\nComment prévenir les complications cardiovasculaires ?\nQuels signes indiquent une complication grave ?",
"url": "https://questionsmedicales.fr/mesh/D017690#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Transplantation cellulaire",
"description": "Quels facteurs augmentent le risque de rejet ?\nComment le mode de vie affecte-t-il le succès de la transplantation ?\nQuels médicaments augmentent le risque d'infection ?\nComment l'obésité influence-t-elle la transplantation ?\nQuels antécédents médicaux sont préoccupants ?",
"url": "https://questionsmedicales.fr/mesh/D017690#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de transplantation cellulaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur des tests sanguins, biopsies et évaluations cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la compatibilité ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de typage tissulaire et des tests de compatibilité sanguine sont effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une défaillance cellulaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, infections fréquentes et anomalies sanguines peuvent signaler une défaillance."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'état de santé du receveur ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques, imageries et analyses sanguines sont réalisés pour évaluer l'état."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont surveillés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme les cytokines et les enzymes hépatiques sont surveillés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir après une transplantation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur au site de transplantation et signes d'infection sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un rejet de greffe ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur, gonflement et dysfonctionnement de l'organe greffé."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont possibles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets comme nausées, fatigue et troubles immunitaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cellules transplantées ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de cellules et l'organe concerné."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection doivent alerter ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, écoulement et fièvre sont des signes d'infection à surveiller."
}
},
{
"@type": "Question",
"name": "Comment prévenir le rejet de greffe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi strict des médicaments immunosuppresseurs et des consultations régulières sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains fréquemment et éviter les foules pour réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Comment éviter les infections post-transplantation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les contacts avec des personnes malades et suivre les recommandations médicales."
}
},
{
"@type": "Question",
"name": "Quels vaccins sont recommandés avant la transplantation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des vaccins contre la grippe, le pneumocoque et l'hépatite B sont souvent recommandés."
}
},
{
"@type": "Question",
"name": "Comment maintenir un mode de vie sain après la transplantation ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels traitements sont administrés après une transplantation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des immunosuppresseurs et des antibiotiques sont souvent prescrits pour prévenir le rejet."
}
},
{
"@type": "Question",
"name": "Comment gérer le rejet de greffe ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le rejet est traité par des ajustements de médicaments immunosuppresseurs et des soins médicaux."
}
},
{
"@type": "Question",
"name": "Quelles sont les options de traitement en cas de complications ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent nécessiter des traitements spécifiques comme des transfusions ou des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de cellules ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent différer selon le type de cellules transplantées et l'état du receveur."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire après la transplantation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec des examens cliniques et des tests sanguins est essentiel."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles après une transplantation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le rejet, les infections et les problèmes de coagulation."
}
},
{
"@type": "Question",
"name": "Comment gérer une infection post-transplantation ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement antibiotique et un suivi médical régulier sont nécessaires pour gérer les infections."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de cancer après une transplantation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients transplantés ont un risque accru de certains cancers en raison des immunosuppresseurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications cardiovasculaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un contrôle régulier de la pression artérielle et un mode de vie sain aident à prévenir ces complications."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs intenses, des saignements ou des changements d'état mental doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de rejet ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, les antécédents médicaux et la compatibilité tissulaire influencent le risque de rejet."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie affecte-t-il le succès de la transplantation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, sans tabac et avec une bonne alimentation, favorise le succès."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les immunosuppresseurs et certains antibiotiques peuvent augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Comment l'obésité influence-t-elle la transplantation ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité peut compliquer la chirurgie et augmenter le risque de complications post-opératoires."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont préoccupants ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de maladies auto-immunes ou de cancers augmentent les risques liés à la transplantation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 23/03/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Hematology, Hokkaido University Hospital, Hokkaido, Japan.
Publications dans "Transplantation cellulaire" :
3 publications dans cette catégorie
Affiliations :
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Hematology, Hôpital St. Antoine, Paris, France.
Sorbonne University, Paris, France.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Duke University, Durham, NC, United States.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Duke University, Durham, NC, United States.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical and Biomolecular Engineering, 6000 Interdisciplinary Science & Engineering Building (ISEB), Irvine, CA 92617, USA.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical Engineering, Virginia Tech, Blacksburg, VA 24061, USA.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Dale E. and Sarah Ann Fowler School of Engineering, Chapman University, Orange, CA 92866, USA. Electronic address: mreza.mhmdi@gmail.com.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology and Oncology, Okayama University Hospital, 2-5-1 Shikatacho, Kita-ku, Okayama-city, Okayama, 700-8558, Japan. k-matsu@md.okayama-u.ac.jp.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology and Oncology, Okayama University Hospital, 2-5-1 Shikatacho, Kita-ku, Okayama-city, Okayama, 700-8558, Japan.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Hematology and Oncology, Okayama University Hospital, 2-5-1 Shikatacho, Kita-ku, Okayama-city, Okayama, 700-8558, Japan.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Division of Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, No. 125, Lih-Der Road, Pei-Tou District, Taipei, 112, Taiwan. trander@kfsyscc.org.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Research Center for Horse Industry, Kyungpook National University, Sangju 37224, Korea.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Research Center for Horse Industry, Kyungpook National University, Sangju 37224, Korea.
Department of Horse, Companion and Wild Animal Science, Kyungpook National University, Sangju 37224, Korea.
Publications dans "Transplantation cellulaire" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine V, University of Heidelberg, Heidelberg.
Publications dans "Transplantation cellulaire" :
The advancement of cell transplantation approaches requires model systems that allow an accurate assessment of transplanted cell functional potency. For the central nervous system, although xenotransp...
This systematic review provides a comprehensive analysis of the efficacy of autologous cell transplant as a therapeutic approach for stable segmental vitiligo. Vitiligo poses significant challenges fo...
Using online medical literature databases and the PRISMA guidelines, six out of 60 articles met the acceptance criteria to be analyzed, emphasizing the lack of current literature on this subject....
Autologous cell transplant achieves excellent pigmentation rates for many body parts. We found that cultivated cells had better results than noncultivated ones. Both types of treatments could pigment ...
This review highlights the importance of autologous cell transplant as a new and reliable tool for the treatment of stable segmental vitiligo, cultured transplants being the most effective. By employi...
Immature teeth with necrotic pulps present multiple challenges to clinicians. In such cases, regenerative endodontic procedures (REPs) may be a favorable strategy. Cells, biomaterial scaffolds, and si...
A 31-year-old woman presented to our clinic with the chief complaint of occlusion discomfort in the left mandibular posterior region for the past 5 years. Tooth #35 showed no pulp vitality and had a p...
hDPCs combined with LPCGF represents an innovative and effective strategy for cell-based regenerative endodontics....
We previously demonstrated that CD34 + cell transplantation in animals healed intractable fractures via osteogenesis and vasculogenesis; we also demonstrated the safety and efficacy of this cell thera...
CD34 + cells were mobilized via administration of granulocyte colony-stimulating factor, harvested using leukapheresis, and isolated using magnetic cell sorting. Autologous CD34 + cells were transplan...
All fractures healed during the study period. The time to radiological fracture healing was 2.8 times shorter in patients with CD34 + cell transplantation than in the historical control group (hazard ...
Our findings strongly suggest that autologous CD34 + cell transplantation is a novel treatment option for fracture nonunion....
UMIN-CTR, UMIN000022814. Registered on 22 June 2016....
The first product in the world for ex vivo cultivated oral mucosal epithelial cell transplantation (COMET) to treat limbal stem cell deficiency (LSCD), named Ocural...
A previous, proof-of-concept clinical study suggested that dermal sheath cup cell injections into the affected areas of male/female pattern hair loss (PHL) may have some amelioratory effects, the clin...
The endocrine system, consisting of the hypothalamus, pituitary, endocrine glands, and hormones, plays a critical role in hormone metabolic interactions. The complexity of the endocrine system is a si...
The autologous noncultured melanocyte keratinocyte transplant procedure (MKTP) has emerged as a popular grafting technique with proven efficacy for achieving repigmentation. However, there remains no ...
A total of 69 patients (mean [SD] age was 32.4 [14.3] years, mean follow-up was 30.4 [22.5] months, 63.8% were male; 55% were dark-skinned individuals [Fitzpatrick IV-VI]) were included. The mean perc...
In our study, we found that patients with SV were significantly more likely to achieve higher repigmentation rates compared to those with NSV. Although repigmentation rates were higher in the low expa...
MKTP is an effective therapy for restoring repigmentation in patients with stable vitiligo. Therapeutic response of vitiligo to MKTP appears to be influenced by the type of vitiligo, rather than a spe...
One major limitation for broader applicability of allogeneic hematopoietic cell transplantation (allo-HCT) in the past was the lack of HLA-matched histocompatible donors. Preclinical mouse studies usi...
While acknowledging that no randomized controlled prospective studies have been yet conducted comparing TCD versus PTCy in haploidentical allo-HCT recipients, there are two advantages that would favor...
Disparities in access to hematopoietic cell transplant (HCT) are well established. Prior studies have identified barriers, such as referral and travel to an HCT center, that occur before consultation....